Invention Grant
- Patent Title: Recombinant protein antigen of Orientia tsutsugamushi and vaccine composition using the same
-
Application No.: US16472104Application Date: 2017-12-21
-
Publication No.: US10961284B2Publication Date: 2021-03-30
- Inventor: Nam Hyuk Cho , Na Young Ha
- Applicant: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
- Applicant Address: KR Seoul
- Assignee: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
- Current Assignee: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
- Current Assignee Address: KR Seoul
- Agency: Harness, Dickey & Pierce, PLC
- Priority: KR10-2016-0176031 20161221
- International Application: PCT/KR2017/015251 WO 20171221
- International Announcement: WO2018/117691 WO 20180628
- Main IPC: C07K14/29
- IPC: C07K14/29 ; A61K39/02 ; A61K39/39 ; C07K16/12 ; G01N33/569 ; A61K39/00
Abstract:
The present invention discloses a novel recombinant protein antigen and a vaccine composition using the same, in which the novel recombinant protein antigen is derived from the conserved sequence of a TSA56 antigen and can be useful in the diagnosis of infection with tsutsugamushi and as a vaccine for tsutsugamushi.
Public/Granted literature
- US20190330283A1 Novel Recombinant Protein Antigen Of Orientia Tsutsugamushi And Vaccine Composition Using The Same Public/Granted day:2019-10-31
Information query
